86 related articles for article (PubMed ID: 2253892)
1. Ergoloid mesylates vs. Alzheimer's: the latest round.
Walker C
Geriatrics; 1990 Dec; 45(12):22, 24. PubMed ID: 2253892
[No Abstract] [Full Text] [Related]
2. Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.
Jenike MA; Albert MS; Heller H; LoCastro S; Gunther J
J Clin Psychiatry; 1986 May; 47(5):249-51. PubMed ID: 3700343
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of hydergine in patients with Alzheimer's disease.
Thompson TL; Filley CM; Mitchell WD; Culig KM; LoVerde M; Byyny RL
N Engl J Med; 1990 Aug; 323(7):445-8. PubMed ID: 2082953
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term ergoloid mesylates ('Hydergine') administration in healthy pensioners: 5-year results.
Huber F; Köberle S; Prestele H; Spiegel R
Curr Med Res Opin; 1986; 10(4):256-79. PubMed ID: 3780290
[TBL] [Abstract][Full Text] [Related]
5. Ergoloid mesylates for senile dementias: unanswered questions.
Hollister LE; Yesavage J
Ann Intern Med; 1984 Jun; 100(6):894-8. PubMed ID: 6372566
[TBL] [Abstract][Full Text] [Related]
6. Ergoloid mesylates and ECT.
Sachs GS; Gelenberg AJ; Bellinghausen B; Wojcik J; Falk WE; Farhadi AM; Jenike M
J Clin Psychiatry; 1989 Mar; 50(3):87-90. PubMed ID: 2647711
[TBL] [Abstract][Full Text] [Related]
7. Mild cognitive impairment, healthy aging and Alzheimer's disease.
Wu CK
Med Health R I; 2008 May; 91(5):132-3. PubMed ID: 18549037
[No Abstract] [Full Text] [Related]
8. Hydergine helpful for Alzheimer's disease.
Geriatrics; 1979 Oct; 34(10):23. PubMed ID: 478308
[No Abstract] [Full Text] [Related]
9. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of hydergine in Alzheimer's disease.
Posner JD; Landsberg L
N Engl J Med; 1991 Jan; 324(3):197-8. PubMed ID: 1984200
[No Abstract] [Full Text] [Related]
11. Alzheimer's disease: clinical features and pharmacologic management.
Franks AS; Rawls WN
Am J Manag Care; 1998 Apr; 4(4):595-604; quiz 606-7. PubMed ID: 10179918
[No Abstract] [Full Text] [Related]
12. Navigating patients and caregivers through the course of Alzheimer's disease.
Aupperle PM
J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846
[TBL] [Abstract][Full Text] [Related]
13. Rofecoxib in mild cognitive impairment.
Ownby RL
Curr Psychiatry Rep; 2006 Feb; 8(1):9-10. PubMed ID: 16513035
[No Abstract] [Full Text] [Related]
14. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Antuono PG
Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
[TBL] [Abstract][Full Text] [Related]
15. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
Thibault A
Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
[No Abstract] [Full Text] [Related]
16. Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease.
Clipp EC; Moore MJ
Clin Pharmacol Ther; 1995 Aug; 58(2):228-36. PubMed ID: 7648773
[TBL] [Abstract][Full Text] [Related]
17. New developments in the treatment of Alzheimer's disease.
J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
[No Abstract] [Full Text] [Related]
18. Diagnosis and treatment of Alzheimer's disease.
Grossberg GT
J Clin Psychiatry; 2003; 64 Suppl 9():3-6. PubMed ID: 12934967
[TBL] [Abstract][Full Text] [Related]
19. Is donepezil effective for treating Alzheimer's disease?
Steele LS; Glazier RH
Can Fam Physician; 1999 Apr; 45():917-9. PubMed ID: 10216789
[No Abstract] [Full Text] [Related]
20. Letter: "Happy death day".
Cohen C
Br Med J; 1975 Dec; 4(5996):581. PubMed ID: 812583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
